• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Epitope specific T cell responses against influenza A in a healthy population

tetano

Editor, Senior Moderator
Immunology. 2015 Oct 22. doi: 10.1111/imm.12548. [Epub ahead of print]
[h=1]Epitope specific T cell responses against influenza A in a healthy population.[/h] Savic M[SUP]1,[/SUP][SUP]2[/SUP], Dembinski JL[SUP]1,[/SUP][SUP]2[/SUP], Kim Y[SUP]3[/SUP], Tunheim G[SUP]1,[/SUP][SUP]2[/SUP], Cox RJ[SUP]2,[/SUP][SUP]4[/SUP], Oftung F[SUP]1,[/SUP][SUP]2[/SUP], Peters B[SUP]3[/SUP], Mjaaland S[SUP]1,[/SUP][SUP]2[/SUP].
[h=3]Author information[/h]

[h=3]Abstract[/h] Pre-existing human CD4[SUP]+[/SUP] and CD8[SUP]+[/SUP] T cell mediated immunity may be a useful correlate of protection against severe influenza disease. Identification and evaluation of common epitopes recognized by T cells with broad cross-reactivity is therefore important to guide universal influenza vaccine development, and to monitor immunological preparedness against pandemics. We have retrieved an optimal combination of MHC class I and II restricted epitopes from the Immune Epitope Database (www .iedb org), by defining a fitness score function depending on prevalence, sequence conservancy, and HLA super type coverage. Optimized libraries of CD4[SUP]+[/SUP] and CD8[SUP]+[/SUP] T cell epitopes were selected from influenza antigens commonly present in seasonal and pandemic influenza strains from 1934-2009. These epitope pools were used to characterize human T cell responses in healthy donors using IFNγ Elispot assays. Upon stimulation, significant CD4[SUP]+[/SUP] and CD8[SUP]+[/SUP] T cell responses were induced, primarily recognizing epitopes from the conserved viral core proteins. Furthermore, the CD4[SUP]+[/SUP] and CD8[SUP]+[/SUP] T cells were phenotypically characterized regarding functionality, cytotoxic potential, and memory phenotype using flow cytometry. Optimized sets of T cell peptide epitopes may be a useful tool to monitor the efficacy of clinical trials, the immune status of a population to predict immunological preparedness against pandemics, as well as being candidates for universal influenza vaccines. This article is protected by copyright. All rights reserved.
This article is protected by copyright. All rights reserved.


[h=4]KEYWORDS:[/h] Influenza A virus; T cell epitopes; biomarkers; cross-reactivity; vaccine

PMID: 26489873 [PubMed - as supplied by publisher]
 
Back
Top Bottom